AI assistant
Pluri Inc. — Director's Dealing 2016
Feb 24, 2016
6990_rns_2016-02-24_500d0e2f-4c68-4a77-b183-917177e0640d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Check this box if no longer subject to Section 16. Form 4 STATEMENT OF CHANGES IN BENEFICIAL
or Form 5 obligations may OWNERSHIP continue. See Instruction 1(b).
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours 0.5 per response
- Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer 1. Name and Address of Reporting Person[*] PLURISTEM THERAPEUTICS (Check all applicable) Aberman Zami 0001344740 INC [ PSTI ] X Director 10% Owner (Last) (First) (Middle) X Officer (give title below) Other (specify below) 3. Date of Earliest Transaction (Month/Day/Year) 46 HATAPUZ ST. 02/22/2016 CEO & Chairman (Street) 4. If Amendment, Date of Original Filed 6. Individual or Joint/Group Filing (Check (Month/Day/Year) Applicable Line) TEL MOND L3 40600 X Form filed by One Reporting Person Form filed by More than One Reporting Person (City) (State) (Zip) Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) 5. Amount of 6. 7. Nature Date Execution Date, if Transaction or Disposed Of (D) (Instr. Securities Ownership of Indirect (Month/Day/Year) any Code (Instr. 3, 4 and 5) Beneficially Form: Direct Beneficial (Month/Day/Year) 8) Owned (D) or Ownership Following Indirect (I) (Instr. 4) (A) Reported (Instr. 4) Code V Amount or Price Transaction(s) (D) (Instr. 3 and 4) Common Stock 2,118,298 D By Rose Common Stock 02/22/2016 P 5,000 A $1.33 111,400 I Hitech Ltd.
Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
- Title of 2. 3. Transaction 3A. Deemed 4. 5. 6. Date Exercisable and 7. Title and 8. Price 9. Number 10. 11. Nature Derivative Conversion Date Execution Date, if Transaction Number Expiration Date Amount of of of Ownership of Indirect Security or Exercise (Month/Day/Year) any Code (Instr. of (Month/Day/Year) Securities Derivative Derivative Form: Beneficial (Instr. 3) Price of (Month/Day/Year) 8) Derivative Underlying Security Securities Direct (D) Ownership Derivative Securities Derivative (Instr. 5) Beneficially or Indirect (Instr. 4) Security Acquired Security (Instr. Owned (I) (Instr. (A) or 3 and 4) Following 4) Disposed Reported of (D) Transaction (Instr. 3, (s) (Instr. 4) 4 and 5) Amount or Number Date Expiration of Code V (A) (D) Exercisable Date Title Shares
Explanation of Responses:
Remarks:
/s/ Zami Aberman 02/24/2016 Date
- ** Signature of Reporting Person
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.